DYL will be the sleeper full of cash and experts running it with Rick Rule a major shareholder its a win win no funding or dillution,
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025